Suspension of trading

Valuation Deciphera Pharmaceuticals, Inc.

Stocks

Market Closed - Nasdaq 00:00:00 11/06/2024 +04			5-day change	1st Jan Change
25.59 ^USD	+0.08%		-.--%	-

06-17	Deciphera Pharmaceuticals, LLC Doses First Patient In Pivotal Phase 3 INTREPID Study Of Sapablursen In Polycythemia Vera	CI
03-26	Ono Pharmaceutical Co., Ltd. Submits Application for Approval of Ripretinib in Japan	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2018	2019	2020	2021	2022	2023
Market Cap ¹	790.5	3,177	3,249	571.4	1,108	1,292
Change	-	301.89%	2.27%	-82.42%	93.85%	16.69%
Enterprise Value (EV) ¹	509.4	2,615	2,719	274.6	797.6	965.4
Change	-	413.37%	3.98%	-89.9%	190.44%	21.02%
P/E	-7.44x	-13.9x	-11.9x	-1.89x	-6.92x	-7.04x
PBR	2.82x	5.88x	6.05x	1.85x	3.24x	3.7x
PEG	-	-0.2x	-1.82x	-0.23x	0.1x	2.14x
Capitalization / Revenue	-	127,078,923x	77,201,761x	5,942,482x	8,263,239x	7,911,471x
EV / Revenue	-	-	-	-	-	-
EV / EBITDA	-4.91x	-13.2x	-10.1x	-1.01x	-4.44x	-4.62x
EV / EBIT	-4.89x	-13.2x	-10x	-1x	-4.37x	-4.58x
EV / FCF	-9.58x	-33.3x	-18.8x	-2.23x	-9.28x	-13.3x
FCF Yield	-10.4%	-3%	-5.31%	-44.8%	-10.8%	-7.54%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-2.821	-4.485	-4.777	-5.164	-2.37	-2.292
Distribution rate	-	-	-	-	-	-
Net sales	-	25	42.09	96.15	134	163.4
EBITDA ¹	-103.8	-197.5	-268.9	-270.9	-179.8	-208.9
EBIT ¹	-104.1	-198.3	-271.2	-273.9	-182.7	-211
Net income ¹	-99.85	-192.3	-266.5	-300	-178.9	-194.9
Net Debt ¹	-281.1	-561.9	-530.1	-296.7	-309.9	-327
Reference price ²	20.99	62.24	57.07	9.77	16.39	16.13
Nbr of stocks (in thousands)	37,661	51,044	56,933	58,481	67,576	80,123
Announcement Date	14/03/19	09/03/20	09/02/21	08/02/22	07/02/23	07/02/24

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
DECIPHERA PHARMACEUTICALS, INC.	-	-	-	-	2.21B
WUXI APPTEC CO., LTD.	20.44x	7.17x	14.49x	1.43%	68.87B
ARGENX SE	37.07x	9.67x	29.5x	0.04%	65.29B
INSMED INCORPORATED	-77.51x	14.96x	-72.15x	-.--%	27.65B
WUXI BIOLOGICS (CAYMAN) INC.	29.76x	6.36x	16.52x	-.--%	25.77B
BIONTECH SE	-15.9x	6.16x	-7.74x	-.--%	26.08B
GENMAB A/S	27.51x	5.14x	17.12x	-.--%	20.14B
PHARMAESSENTIA CORPORATION	49.22x	18.16x	36.83x	0.31%	17.03B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	1298.7x	37.56x	819.65x	-.--%	15.03B
EXELIXIS, INC.	18.08x	5.39x	12.58x	-.--%	14.5B
Average	154.15x	12.29x	96.31x	0.2%	28.26B
Weighted average by Cap.	82.77x	10.41x	52.16x	0.38%